C4 Therapeutics, Inc. (CCCC) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,038
Total Return
-89.62%
CAGR
-36.44%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.81% |
| Median | -5.45% |
| Best | +513.55% |
| Worst | -66.16% |
| % of Windows Positive | 41.3% |
1-Year (252 Trading Days)
| Average | -13.09% |
| Median | -58.32% |
| Best | +360.72% |
| Worst | -88.51% |
| % of Windows Positive | 28.5% |
3-Year (756 Trading Days)
| Average | -72.10% |
| Median | -79.83% |
| Best | +39.78% |
| Worst | -95.19% |
| % of Windows Positive | 2.6% |
Risk Metrics
| Maximum Drawdown | -97.82% |
| Average Drawdown | -79.44% |
| Drawdown Duration | 1177 Trading Days (Unrecovered) |
| Sortino Ratio | 0.20 |
| Calmar Ratio | -0.37 |
| CVaR (5%) | -11.79% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +107.33% (+463.70% ann.) | +$10733.07 | $0.00 | $0.00 | $0.00 |
| 2025 | -46.94% | $4694.47 | $0.00 | $0.00 | $0.00 |
| 2024 | -36.28% | $3628.32 | $0.00 | $0.00 | $0.00 |
| 2023 | -4.24% | $423.70 | $0.00 | $0.00 | $0.00 |
| 2022 | -81.68% | $8167.71 | $0.00 | $0.00 | $0.00 |
| 2021 | -2.81% | $280.71 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +29.97% (+189.77% ann.) | +$2997.25 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | October 2, 2020 – November 6, 2020 | +5.81% | +80.22% | +$580.62 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +35.10% | +33.03% | +$3509.96 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -78.99% | -80.92% | $7898.71 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -26.51% | -15.31% | $2650.73 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -37.93% | -24.39% | $3793.10 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.